Profilo
Karen J.
LaRochelle currently works at Advent Venture Partners LLP, as Operating Partner, Advent Life Sciences LLP, as Partner from 2020, and WindMIL Therapeutics, Inc., as SVP, Corporate & Business Development from 2020.
Ms. LaRochelle also formerly worked at PaxMedica, Inc., as Independent Director from 2020 to 2025, Bristol Myers Squibb Co., as Head-Negotiations Division from 1993 to 2013, Artax Biopharma, Inc., as Chief Business Officer from 2020 to 2024, Akamis Bio Ltd., as Chief Business Officer from 2016 to 2019, and Larochelle Advisors LLC, as Principal from 2013 to 2016.
Ms. LaRochelle received her Masters Business Admin degree from The Trustees of Columbia University in The City of New York and undergraduate degree from Lehigh University.
Posizioni attive di Karen LaRochelle
| Società | Posizione | Inizio |
|---|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Investitore di Private Equity | 01/01/2020 |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Corporate Officer/Principal | 01/01/2020 |
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Engages in production of small molecules, biologics and enabling technologies and vaccines | Corporate Officer/Principal | 01/01/2020 |
Precedenti posizioni note di Karen LaRochelle
| Società | Posizione | Fine |
|---|---|---|
| PAXMEDICA, INC. | Direttore/Membro del Consiglio | 02/04/2025 |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapies for autoimmune and inflammatory diseases | Corporate Officer/Principal | 04/01/2024 |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Corporate Officer/Principal | 01/01/2019 |
Larochelle Advisors LLC | Corporate Officer/Principal | 01/01/2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/05/2013 |
Formazione di Karen LaRochelle
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Finance |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapies for autoimmune and inflammatory diseases | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Health Technology |
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Engages in production of small molecules, biologics and enabling technologies and vaccines | Health Technology |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops and offers immunotherapies to treat cancer patients | Health Technology |
PaxMedica, Inc.
PaxMedica, Inc. BiotechnologyHealth Technology Develops anti-purinergic therapies treatments for neurodevelopmental disorders | Health Technology |
Larochelle Advisors LLC |
















